Clinical Trial Update: Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating paclitaxel-eluting balloons and everolimus-eluting coronary stents using optical coherence tomography; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Paclitaxel-eluting balloon (paclitaxel)

Snippet

Sponsor: University of Jena | Conditions: Stents, Neointimal Proliferation | Phase 4 | Status: COMPLETED